Annual Working Capital
$152.66 M
-$89.99 M-37.09%
December 31, 2023
Summary
- As of February 7, 2025, ALXO annual working capital is $152.66 million, with the most recent change of -$89.99 million (-37.09%) on December 31, 2023.
- During the last 3 years, ALXO annual working capital has fallen by -$277.13 million (-64.48%).
- ALXO annual working capital is now -64.48% below its all-time high of $429.79 million, reached on December 31, 2020.
Performance
ALXO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$123.56 M
-$6.71 M-5.15%
September 30, 2024
Summary
- As of February 7, 2025, ALXO quarterly working capital is $123.56 million, with the most recent change of -$6.71 million (-5.15%) on September 30, 2024.
- Over the past year, ALXO quarterly working capital has dropped by -$40.37 million (-24.63%).
- ALXO quarterly working capital is now -71.25% below its all-time high of $429.79 million, reached on December 31, 2020.
Performance
ALXO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ALXO Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.1% | -24.6% |
| 3 y3 years | -64.5% | -59.6% |
| 5 y5 years | +1731.5% | -70.5% |
ALXO Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -56.6% | at low | -64.9% | at low |
| 5 y | 5-year | -64.5% | +3063.9% | -71.3% | +2460.7% |
| alltime | all time | -64.5% | +3063.9% | -71.3% | +2460.7% |
ALX Oncology Holdings Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $123.56 M(-5.1%) |
| Jun 2024 | - | $130.26 M(-4.0%) |
| Mar 2024 | - | $135.64 M(-11.2%) |
| Dec 2023 | $152.66 M(-37.1%) | $152.66 M(-6.9%) |
| Sep 2023 | - | $163.93 M(-18.8%) |
| Jun 2023 | - | $201.99 M(-4.1%) |
| Mar 2023 | - | $210.65 M(-13.2%) |
| Dec 2022 | $242.64 M | $242.64 M(-8.6%) |
| Sep 2022 | - | $265.56 M(-9.3%) |
| Jun 2022 | - | $292.89 M(-4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $306.22 M(-12.9%) |
| Dec 2021 | $351.72 M(-18.2%) | $351.72 M(-6.6%) |
| Sep 2021 | - | $376.48 M(-5.5%) |
| Jun 2021 | - | $398.30 M(-4.8%) |
| Mar 2021 | - | $418.20 M(-2.7%) |
| Dec 2020 | $429.79 M(+8807.5%) | $429.79 M(+68.4%) |
| Sep 2020 | - | $255.21 M(+174.6%) |
| Jun 2020 | - | $92.94 M(-10.1%) |
| Mar 2020 | - | $103.42 M(+2043.5%) |
| Dec 2019 | $4.83 M(-42.1%) | $4.83 M |
| Dec 2018 | $8.34 M | - |
FAQ
- What is ALX Oncology Holdings annual working capital?
- What is the all time high annual working capital for ALX Oncology Holdings?
- What is ALX Oncology Holdings annual working capital year-on-year change?
- What is ALX Oncology Holdings quarterly working capital?
- What is the all time high quarterly working capital for ALX Oncology Holdings?
- What is ALX Oncology Holdings quarterly working capital year-on-year change?
What is ALX Oncology Holdings annual working capital?
The current annual working capital of ALXO is $152.66 M
What is the all time high annual working capital for ALX Oncology Holdings?
ALX Oncology Holdings all-time high annual working capital is $429.79 M
What is ALX Oncology Holdings annual working capital year-on-year change?
Over the past year, ALXO annual working capital has changed by -$89.99 M (-37.09%)
What is ALX Oncology Holdings quarterly working capital?
The current quarterly working capital of ALXO is $123.56 M
What is the all time high quarterly working capital for ALX Oncology Holdings?
ALX Oncology Holdings all-time high quarterly working capital is $429.79 M
What is ALX Oncology Holdings quarterly working capital year-on-year change?
Over the past year, ALXO quarterly working capital has changed by -$40.37 M (-24.63%)